Janney Sees Potential DepoMed (DEPO) Court Decision Delay

September 28, 2016 7:39 AM EDT
Get Alerts DEPO Hot Sheet
Price: $18.94 +2.10%

Rating Summary:
    10 Buy, 5 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 11 | Down: 31 | New: 42
Trade DEPO Now!
Join SI Premium – FREE

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Janney Montgomery Scott analyst Ken Trbovich said with the Court's self-imposed Sep. 30th deadline for DepoMed (NASDAQ: DEPO) patent litigation fast approaching, there is rising risk of delay. While the analyst remains positive on the stock overall, he warns a delay may lead to downside pressure on the stock.

Trbovich commented, "Investors have waited for four months for the District Court decision in DEPO's patent litigation with generic filers; however, with the Court's self-imposed Sep. 30th deadline fast approaching, there is rising risk of delay. We see a delay as a possibility because the judge in this case was slow in issuing the Markman Decision in February, and waited until nearly reaching the expiration of the initial 30-month stay before issuing an order to extend the stay in May. DEPO continues to expect a final, written decision from the Court on, or before, Sep. 30th. While we still like the prospects for a positive decision to increase the perceived value of DEPO's Nucynta franchise in the public markets, and DEPO's relative attractiveness as a takeout candidate, we caution investors that a delay may lead to downside pressure on the stock."

The firm maintained a Buy rating and fair value target of $28.

For an analyst ratings summary and ratings history on DepoMed Inc click here. For more ratings news on DepoMed Inc click here.

Shares of DepoMed Inc closed at $24.40 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments, FDA, Hot Comments, Litigation, Trader Talk

Related Entities

Janney Montgomery Scott

Add Your Comment